Christopher A. D'Avella

Christopher A. D'Avella, MD, serves as Clinical Assistant Professor of Medicine at the University of Pennsylvania, where he holds dual leadership roles as Section Chief of Hematology/Oncology at Penn Presbyterian Medical Center and Co-Director of the Cancer Diagnostics Clinic. Board-certified in Hematology and Medical Oncology, he maintains an active clinical practice at Abramson Cancer Center with exceptional patient satisfaction ratings (4.9/5 from 242 reviews) and specializes in care for adults aged 18+.

His educational background includes:

• Medical School: George Washington University
• Residency: University of Pittsburgh Medical Center
• Fellowship: Temple University Hospital

Dr. D'Avella's research program centers on revolutionizing cancer diagnostics through rapid-access clinic models, addressing financial toxicity in underserved urban populations, and optimizing NSCLC treatment pathways with immunotherapies. His work integrates clinical operations with quality improvement, focusing on reducing diagnostic delays, implementing financial screening tools, and analyzing real-world outcomes for durvalumab/osimertinib regimens. This translational approach bridges frontline oncology practice with actionable research to improve equity in cancer care.

His 10 recent publications (2023-2025) demonstrate consistent focus on healthcare delivery science, with 70% addressing diagnostic acceleration or financial barriers, and 30% analyzing NSCLC treatment outcomes. Key venues include ASCO Quality Care Symposium (6 presentations) and high-impact journals like JAMA Network Open and Clinical Lung Cancer, reflecting his specialization in oncology quality improvement rather than basic science.

As Section Chief and Clinic Co-Director, Dr. D'Avella mentors trainees through clinical rotations and quality improvement projects rather than formal graduate supervision. His leadership in the Cancer Diagnostics Clinic creates structured opportunities for medical students and residents to engage in patient navigation, data collection for operational research, and implementation of financial toxicity screening protocols within Penn Medicine's safety-net hospital system.

The Cancer Diagnostics Clinic functions as his primary operational unit—a multidisciplinary team integrating oncologists, nurses, social workers, and financial advocates to streamline diagnostic pathways. This model serves as both a clinical service and living laboratory for his research on timely cancer care, with active collaborations across Penn Medicine's Abramson Cancer Center and urban health initiatives.